EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 455 participants.

Also called NCT01119300

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking
Phase
Phase 4
Enrolled
  • 455 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01119300
Main results
  • A randomized trial of genotype-guided dosing of warfarin The New England journal of medicine, 2013-12-12 DOI, PubMed 24251363

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01119300. Randomized; single masking. Start 2011-01 (registry gives no type); primary completion 2013-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin
Acronym
EU-PACT
Condition
Venous Thromboembolism
Intervention (Other)
Genotype-guided dosing algorithm
Intervention (Other)
Standard care
Lead sponsor
Utrecht Institute for Pharmaceutical Sciences (class: other)
Collaborator
Utrecht University (class: other)
Collaborator
Leiden University Medical Center (class: other)
Collaborator
Erasmus Medical Center (class: other)
Collaborator
University of Ulm (class: other)
Collaborator
Newcastle University (class: other)
Collaborator
University of Liverpool (class: other)
Collaborator
LGC Limited (class: industry)
Collaborator
Uppsala University (class: other)
Collaborator
Democritus University of Thrace (class: other)
Collaborator
Elisabethinen Hospital (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 11

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

    Organization03bfqnx40

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.

    Organization05xvt9f17

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

    Organization04xs57h96

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 24 trials in this atlas.

    Organization048a87296

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

Record details

Record id
cardio:ct-nct01119300
Content hash
ec6841e30384b2d54c32a1cb97bcb1ae4ef3a0cf58e519c584654c502b3ee412